CARPL
5 articles published
CARPL.ai Expands European Reach With New CE Mark for Radiology AI Platform
\n CARPL.ai has become the first Radiology AI platform to receive a CE mark, enabling healthcare institutions across Europe to access and deploy over 80 AI appl...
CARPL.ai Expands European Reach With New CE Mark for Radiology AI Platform
\n CARPL.ai has become the first Radiology AI platform to receive a CE mark, enabling healthcare institutions across Europe to access and deploy over 80 AI appl...
CARPL.ai Receives US-FDA Clearance to Make Clinical AI Deployment Safer
\n CARPL.ai has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its cutting-edge enterprise imaging AI platform.
CARPL.ai Receives US-FDA Clearance to Make Clinical AI Deployment Safer
\n CARPL.ai has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its cutting-edge enterprise imaging AI platform.
World’s Largest Radiology AI Marketplace CARPL Raises $6 Million to Accelerate the Adoption of AI in Clinical Workflows
Stellaris Venture Partners leads $6 million investment into CARPL, the world’s first enterprise-grade testing, deployment and monitoring platform for radiology AI applications. CARPL is used by the world’s leading healthcare providers to improve the productivity of their radiologists and the quality of care delivered to their patients.